abcdefghijklmn
opqrstuvwxyz
Test Menu
Test Change Details
Allergy & Immunology
Cardiology & Coagulation
Dermatopathology
Endocrinology
Gastroenterology
Genetics
Hepatology
Infectious Disease
Microbiology
Nephrology
Neurology
Oncology
Pathology
Pediatrics
Rheumatology
Toxicology
Urology
Women's Health
16165: Serum Integrated Screen, Part 1 Print View
Comment      
Referring Physician Name      
Referring Physician Phone      
Referring Physician NPI      
Date of Birth      
Collection Date      
Maternal Weight     lbs 
Est'd Date of Delivery      
EDD Determined by      
Mother's Ethnic Origin      
Number of Fetuses      
Insulin Depend Diabetic      
Repeat Specimen      
Hx of Neural Tube Defects      
Brief History (NTD)      
Prev Pregnancy Down Synd      
Donor Egg      
Donor Age: Egg Retrieval      

PRIMARY
1 Serum 1.5 (0.8) mL   Room Temperature - 7 Day(s)/Refrigerated - 7 Day(s)/Frozen - 60 Day(s)  
ALTERNATE

When used in conjunction with Part 2 testing, to assess maternal risk for carrying a fetus with Down Syndrome (Trisomy 21), Trisomy 18, or a neural tube defect. Both part 1 and part 2 are necessary to generate the risk assessment. These types of tests are standard-of-care in obstetrics.

Collect between 9.0 weeks to 13 6/7 weeks. Must complete patient
demographic information using the "Maternal Serum Screen Requisition".
Setup Schedule
Monday-Saturday

Reported (Analytical Time)
Next day


Notes
Not for California Clients or New York patient testing. Reject Criteria: Moderate hemolysis; Gross hemolysis; Lipemic (unacceptable) METHODOLOGY: Immunoassay, Chemiluminescence






1996 - 2017 Quest Diagnostics Nichols Institute of Valencia
For test information, please call Client Services at 800-421-4449.

San Francisco Web Design & Database